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Abstract 
Aims: Prolonged tourniquet inflation produces a hyperdynamic cardiovascular response. We 
investigated the effect of continuous remifentanil infusion on systemic arterial pressure, heart 
rate, and cardiac output changes during prolonged tourniquet use in elderly patients under 
sevoflurane/N2O general anesthesia. 
Methods: Thirty female patients scheduled for knee replacement arthroplasty were infused 
with either remifentanil at a target organ concentration of 2.0 ng/mL (remifentanil group, n = 
15) or saline (control group, n = 15) after induction of anesthesia. Anesthesia was maintained 
with sevoflurane and N2O. Heart rate (HR), systolic arterial pressure (SAP), diastolic arterial 
pressure (DAP), cardiac index (CI), total systemic vascular resistance index (TSVRI), BIS, 
end-tidal sevoflurane concentration (EtSEVO), and end-tidal carbon dioxide concentration 
(EtCO2) were measured during the study period. 
Results: There were significant differences in mean HR, SAP, DAP, and EtSEVO over time 
between the groups (P = 0.047, P < 0.001, P = 0.017, and P < 0.001, respectively). There was 
a statistically significant time trend effect (P < 0.001) in HR, SAP, DAP, and CI between the 
groups, with a statistically significant time-group interaction between the two groups (P = 
0.02, 0.007, 0.001, 0.01, respectively). 
Conclusion: The present study demonstrated that infusion with remifentanil prevented an 
increase  in  hemodynamic  pressure  during  tourniquet  inflation  in  elderly  patients  under 
sevoflurane/N2O general anesthesia. 
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Introduction 
Tourniquets are widely used during limb opera-
tions to minimize surgical bleeding and to maintain a 
relatively bloodless field. Exsanguination of the limb 
and inflation of the tourniquet produce an initial in-
crease in arterial pressure. This increase has been at-
tributed to several factors, including an expansion of 
central venous blood in association with a theoretical 
increase in peripheral vascular resistance and delayed 
hypertension, accompanied by ischemia and pain due 
to tourniquet compression [1-3]. These hemodynamic 
changes  are  minimal  in  healthy  young  patients  but 
may not be tolerated by older patients with poor car-
diac reserve [4]. Previous studies have only focused 
on  the  management  of  delayed  tourniquet-induced 
hypertension in young patients [4-7]. 
Remifentanil is a selective µ-opioid receptor ag-
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onist  with  a  rapid  onset,  short  duration,  and  short 
blood/effect-site equilibration half-time. It is effective 
in  preventing  sympathetic  responses  induced  by 
noxious  stimuli.  Some  studies  have  indicated  that 
remifentanil  may  be  associated  with  significant  he-
modynamic  changes  characterized  by  decreases  in 
arterial pressure, heart rate, cardiac output, and sys-
temic vascular resistance [8,9]. Therefore, remifentanil 
have potential for prevention of both initial and de-
layed tourniquet-induced hypertension. 
We investigated the effect of continuous  intra-
venous remifentanil administration on systemic arte-
rial pressure, heart rate, and cardiac output in elderly 
patients  under  sevoflurane/N2O  general  anesthesia 
who were undergoing knee surgery accompanied by 
use of a tourniquet. 
Materials and Methods 
This study was randomized, blinded, and pro-
spective.  The  study  protocol  was  approved  by  our 
Institutional  Review  Board  and  ethical  committee. 
Written  informed  consent  was  obtained  from  each 
patient. Included in the study were 30 female patients 
ranging  in  age  from  51  to  84  years  with  an  ASA 
physical status of class I – II. Study participants were 
scheduled for total knee replacement surgery with a 
tourniquet under sevoflurane/N2O  general anesthe-
sia. Patients with ischemic heart disease and cerebro-
vascular disease were excluded. Fifteen patients each 
were assigned randomly to the control group and the 
remifentanil  group  using  computer-generated  se-
quence numbers.  
Routine  monitors  were  used  including 
non-invasive arterial pressure, EKG, pulse oximetry, 
end-tidal CO2, and anesthetic concentrations. Induc-
tion  of  anesthesia  was  achieved  with  propofol  1.5 
mg/kg  administered  intravenously.  Muscle  relaxa-
tion  was  induced  with  rocuronium  0.6  mg/kg  ad-
ministered intravenously. Anesthesia was maintained 
with sevoflurane. Laryngoscopy was performed fol-
lowing loss of all four twitches from the train-of-four 
test  performed  by  ulnar  nerve  stimulation.  All  pa-
tients received mechanical ventilation with a mixture 
of nitrous oxide (50%) in oxygen (fresh gas flow rate = 
3 L/min, inspiratory: expiratory ratio = 1:2). The in-
spired ventilation was adjusted to obtain an end-tidal 
CO2 partial pressure between 30 and 35 mmHg start-
ing  five  min  after  anesthesia  induction.  This  was 
maintained  for  the  duration  of  the  surgery.  A 
20-gauge catheter was placed in the radial artery for 
continuous  blood  pressure  monitoring.  In  the  rem-
ifentanil  group,  the  infusion  of  remifentanil  was 
started  with  a  target  organ  concentration  of  2.0 
ng/mL  via  a  target-controlled  infusion  system  (Or-
chestra Module DPS, Fresenius-Vial, Brezins, France). 
In the control group, the infusion of saline was per-
formed in the same fashion. The syringes used with 
both groups were labeled with remifentanil in order 
to blind the data collector. Heart rate (HR), systolic 
arterial  pressure  (SAP),  diastolic  arterial  pressure 
(DAP),  end-tidal  carbon  dioxide  concentration 
(EtCO2),  and  end-tidal  sevoflurane  concentration 
(EtSEVO)  were  measured  and  recorded  every  ten 
minutes during the study period. Cardiac index (CI) 
and total systemic vascular resistance index (TSVRI) 
were monitored with transesophageal Doppler ultra-
sound  monitor  (EDUM;  Hemosonic  100®;  Arrow, 
Reading, PA, USA). A standard BIS monitor strip (BIS 
Sensor®, Aspect Medical Systems, Newton, MA, USA) 
was placed on the forehead before induction of anes-
thesia.  The  Bispectral  index  was  displayed  continu-
ously throughout the procedure using a model A 2000 
Spectral EEG monitor (Aspect Medical Systems, Na-
tick, MA, USA) and maintained between 40 and 60. 
Vital signs taken before the inflation of the tourniquet 
were used as the baseline values. The concentration of 
sevoflurane was adjusted when necessary within the 
full range to maintain systolic  arterial pressure  and 
heart  rate  within  20%  of  baseline  and  to  keep  BIS 
values between 40 and 60. In all patients, the limb was 
exsanguinated  with  an  elastic  bandage  before  tour-
niquet inflation. A pneumatic tourniquet was applied 
to the thigh with a layer of “soft-roll” under the wrap. 
The width of the tourniquet cuff was 20 cm in all pa-
tients. 
Escape  medications  were  prepared  for  all  pa-
tients. Ephedrine (3 mg increments) was available for 
hypotension (SAP < 80 mmHg for > 60 s), atropine 
(300  μg  increments)  was  available  for  bradycardia 
(HR < 40 bpm), and esmolol (30 mg increments) was 
available for hypertension (SAP > 200 mmHg for > 60 
s) or tachycardia (HR > 130 bpm for > 60 s). Patient 
data  were  excluded  from  further  analysis  if  these 
drugs were given during the procedure. 
A pilot study with eight patients showed a mean 
maximum SAP (SD) of 123 (8.7) and 147 (8.9) in the 
remifentanil  group  and  the  control  group,  respec-
tively. Therefore, a sample size of five per group was 
calculated  as  being  needed  to  show  a  difference  of 
maximum  SAP  through  25  and  30  mmHg  (SD  9 
mmHg) between groups with an α risk of 0.01 and a β 
risk of 0.1 [7]. However, we recruited 15 patients for 
each group. 
Student’s t test or Fisher’s exact test was used to 
analyze demographic data. HR, SAP, DAP, CI, TSVRI, 
EtCO2, EtSEVO, and BIS were analyzed by repeated 
measurement. All data are expressed as mean ± SD. P 
values of less than 0.05 were considered to be statis-Int. J. Med. Sci. 2012, 9 
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tically significant. 
Results 
Age,  weight,  height,  and  preexisting  medical 
conditions  did  not  significantly  differ  between  the 
groups (Table 1). 
 
Table 1. Demographic data. 
  Group 
  Control  Remifentanil 
Patients (n)  15  15 
Age (yr)  69 ± 10  67 ± 8 
Weight (kg)  65 ± 7  63 ± 9 
Height (cm)  153 ± 4  150 ± 6 
Tourniquet time (min)  87 ± 15  85 ± 14 
Hypertension (n)  6  7 
Diabetes (n)  2  1 
Data are mean ± SD or n. 
 
 
 
There were significant differences in mean HR, 
SAP,  DAP,  and  EtSEVO  during  the  procedure  be-
tween the groups (P = 0.047, P < 0.001, P = 0.017, and P 
<  0.001,  respectively).  There  were  no  differences  in 
mean CI, TSVRI, EtCO2, or BIS over time between the 
groups.  
HR, SAP, DAP, and CI demonstrated a statisti-
cally significant time trend effect (P < 0.001) with a 
statistically  significant  time-group  interaction  be-
tween the two groups (P = 0.02, 0.007, 0.001, 0.01) (Fig. 
1). There were no circumstances that led to the with-
drawal of a patient from the study. 
Discussion 
The  present  study  demonstrates  that  an  intra-
venous infusion of remifentanil significantly reduces 
hemodynamic increase during tourniquet inflation in 
elderly patients under sevoflurane/N2O general an-
esthesia. HR, SAP, DAP, and CI remained stable be-
fore, during, and after tourniquet inflation in the pa-
tients in the remifentanil group. 
In  healthy  orthopedic  patients,  hemodynamic 
changes due to tourniquet inflation and deflation are 
minimal. However, tourniquet-induced hypertension 
can be a serious side effect in patients with cardio-
vascular problems, neurological diseases, or glauco-
ma [2,5]. We recruited elderly female patients for this 
study irrespective of the presence of hypertension or 
diabetes. Therefore, the outcome of this investigation 
could be clinically useful for the treatment of vulner-
able  patients  compared  with  other  studies  using 
healthy subjects [5-7]. 
Hypotension after the induction of anesthesia is 
a  well-recognized  phenomenon  during  surgical 
preparations, such as draping, without any surgical 
stimuli  and  may  be  aggravated  by  deep  anesthesia 
[10-12]. Anesthesiologists tend to lower the anesthetic 
depth during this period in order to avoid worsening 
the hypotension. The immediate increase  in arterial 
pressure after inflation of a tourniquet may be due to 
light anesthesia, painful stimuli as a result of tourni-
quet  inflation,  an  increase  in  systemic  vascular  re-
sistance,  or  an  expansion  of  central  venous  blood 
caused by exsanguination of the limb. 
On  the  other  hand,  the  delayed  hypertension 
observed with the use of a tourniquet is known to be 
related  to  NMDA  receptor  activation  by  peripheral 
noxious stimuli from the extremities and occurs 40-60 
min after inflation [5,6].  
We monitored the CI and TSVRI of patients us-
ing esophageal Doppler ultrasonography throughout 
the study period. Esophageal Doppler ultrasonogra-
phy offers continuous, noninvasive and reproducible 
cardiac output monitoring with less short-term varia-
bility  than  thermodilution  [13,14].  In  the  control 
group of our study, CI increased by 19% ten minutes 
after  tourniquet  inflation  and  returned  to 
near-baseline values after deflation. TSVRI increased 
by 13% ten minutes after inflation and was stable after 
deflation. Girardis et al. [3] demonstrated that CI did 
not change immediately after inflation but afterwards 
increased by 18% , with a further increase to a value 
40%  higher  than  baseline  after  deflation.  They  also 
demonstrated  that  systemic  vascular  resistance  in-
creased by 20% immediately after inflation  with an 
18% decrease after deflation. These differences from 
our findings can be explained by the fact that in the 
Girardis study, CI was calculated by the pulse contour 
method.  In  addition,  their  study  investigated  ten 
young  men  under  propofol  anesthesia.  In  contrast, 
Parmet et al. [15] reported a slight increase in CI with 
stable MAP and TSVRI values after tourniquet defla-
tion  in  34  patients  undergoing  knee  arthroplasty 
during  general  anesthesia.  The  correspondence  of 
these results to those obtained in our investigation can 
be  explained  by  the  similar  nature  of  both  studies. 
Both  studies  investigated  elderly  patients  with  car-
diovascular  disease  undergoing  total  knee  arthro-
plasty. Unlike our study, in the Parmet study, isoflu-
rane concentration did not change from the time of 
tourniquet deflation until the conclusion of the study. 
These results can vary depending on the method of 
monitoring,  the  anesthetic  drugs  used,  the  type  of 
operation, and the status of the patients enrolled in 
the study. Int. J. Med. Sci. 2012, 9 
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Figure 1. Changes in heart rate (HR), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), cardiac index (CI), total systemic 
vascular resistance index (TSVRI), BIS, end-tidal sevoflurane concentraion (EtSEVO), end-tidal carbon dioxide concentration (EtCO2) 
during the surgery. Values are means (SD). Control group (●), and remifentanil group (□). B: baseline, T10-60: 10-60 min after tourniquet 
inflation, D10-20: 10-20 min after tourniquet deflation. * Changes from the baseline values were different (P < 0.05) between the groups. 
† Mean value was higher (P < 0.05) than at baseline within the same group. 
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Remifentanil  stimulates  NMDA  receptors  of 
different  subunit  combinations  (NR1A/2A, 
NR1A/2B)  via  an  allosteric  mechanism  leading  to 
acute  tolerance  [16].  Sevoflurane,  co-administered 
with  remifentanil,  inhibits  NMDA  receptors  in  a 
dose-dependent  manner,  thereby  neutralizing  the 
remifentanil stimulation of these receptors [17-19]. As 
a result, the use of remifentanil with sevoflurane will 
not  aggravate  slow-onset  NMDA-mediated  tourni-
quet pain and subsequent hypertension [20]. 
Our study has several limitations. First, because 
BIS is not sensitive to N2O administration when the 
inspired sevoflurane concentration remains high, we 
do not think we could adequately control the depth of 
anesthesia for both groups while using BIS to monitor 
[21]. Second, the values of EtSEVO were quite differ-
ent  between  the  groups.  We  acknowledge  that  it 
would have been better to standardize the concentra-
tions of sevoflurane between groups; however, it was 
difficult to maintain patient vital signs and BIS within 
normal limits without the use of much more sevoflu-
rane  in  the  control  group  than  in  the  remifentanil 
group. Finally, it is unclear whether remifentanil in-
hibited a hemodynamic response to tourniquet infla-
tion via blockade of the µ receptor-mediated response. 
Further studies regarding this question are needed. 
In  conclusion,  infusion  with  remifentanil  can 
mitigate the hemodynamic increases associated with 
the  use  of  a  tourniquet  in  elderly  patients  under 
sevoflurane/N2O general anesthesia. 
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